The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Khripun A.I.

Pirogov Russian National Research Medical University

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Zairatyants O.V.

Research Institute of Human Morphology;
Moscow State Medical and Dental University named after A.I. Evdokimov

Nikonov E.L.

Pirogov Russian National Research Medical University

Bessarab T.P.

Sverzhevskiy Research Clinical Institute of Otorhinolaryngology

Gurov A.V.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

Kishinevskiy A.E.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Krasnikova D.I.

L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology of the Moscow Health Department

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Romanenko S.G.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Samsonova M.V.

Research Institute of Pulmonology

Timofeeva M.G.

Sverzhevskiy Research Clinical Institute of Otorhinolaryngology

Chernyayev A.L.

Research Institute of Pulmonology;
Research Institute of Human Morphology;
Russian National Research Medical University named after N.I. Pirogov

Mikhaleva L.M.

A.P. Avtsyn Research Institute of Human Morphology

Mishnev O.D.

Russian National Research Medical University named after N.I. Pirogov

Analysis of the first fatal outcome cases of a new coronavirus infection COVID-19 in medical organizations of the state healthcare system of Moscow

Authors:

Khripun A.I., Kryukov A.I., Zairatyants O.V., Nikonov E.L., Bessarab T.P., Gurov A.V., Kishinevskiy A.E., Krasnikova D.I., Kunelskaya N.L., Romanenko S.G., Samsonova M.V., Timofeeva M.G., Chernyayev A.L., Mikhaleva L.M., Mishnev O.D.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2020;23(7): 5‑15

DOI: 10.17116/profmed2020230715

Read: 1463 times

Download PDF (RU)
Contact the author
Table of contents

ANALYSIS OF THE FIRST FATAL OUTCOME CASES OF A NEW CORONAVIRUS INFECTION COVID-19 IN MEDICAL ORGANIZATIONS OF THE STATE HEALTHCARE SYSTEM OF MOSCOW
ANALYSIS OF THE FIRST FATAL OUTCOME CASES OF A NEW CORONAVIRUS INFECTION COVID-19 IN MEDICAL ORGANIZATIONS OF THE STATE HEALTHCARE SYSTEM OF MOSCOW

To cite this article:

Khripun AI, Kryukov AI, Zairatyants OV, et al. Analysis of the first fatal outcome cases of a new coronavirus infection COVID-19 in medical organizations of the state healthcare system of Moscow. Russian Journal of Preventive Medicine. 2020;23(7):5‑15. (In Russ.)
https://doi.org/10.17116/profmed2020230715

Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Vaccination against pneumococcal infe­ction as a mean of redu­cing morbidity and mortality of the adult popu­lation from risk groups in the Russian Fede­ration. (Resolution of the Council of Expe­rts). Russian Journal of Preventive Medi­cine. 2025;(7):7-14
Postoperative peri­tonitis: epidemiology, diagnosis, surgical treatment and prognosis. Piro­gov Russian Journal of Surgery. 2025;(6):104-111
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Prognostic factors for progression and risk chro­nic obstructive pulmonary disease adve­rse outcomes. Journal of Respiratory Medi­cine. 2025;(2):71-78
Mathematical mode­ling of outcomes in patients with clinical combination of ischemic stroke and COVID-19 complicated by multiple organ failure. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):42-49
The stru­cture of causes of death of the adult popu­lation of the Moscow region in 2019 and 2023. Russian Journal of Archive of Pathology. 2025;(3):40-48
Prevalence of postpartum depression in the Russian Fede­ration: a systematic review and meta-analysis. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):74-87
Pancreatoduodenalectomy with hemi­hepatectomy — analysis of clinical expe­rience. P.A. Herzen Journal of Onco­logy. 2025;(3):25-30
Dyna­mics of the main indi­cators of medi­cal care to the popu­lation of the Russian Fede­ration for the period 1993—2023 in the “Oncology” profile. P.A. Herzen Journal of Onco­logy. 2025;(3):71-77
Prediction of mortality in severe ischemic stroke during COVID-19 in patients with multiorgan dysfunction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):120-127
Abstract:

COVID-19 posed a new challenge to the global medical science, and not all traditional approaches used earlier, for example, in the treatment of SARS and other viral infections, were acceptable. On March 20, 2020, the first fatal outcome from a new coronavirus infection was registered in Moscow. By the time the article was published (6 weeks later) more than 1000 deaths were registered. Taking into account the fact that there is still a growth in the number of patients and, consequently, deaths, the analysis of lethal outcomes of the first (in chronological order of patients) seems to be extremely relevant. As information about a new coronavirus infection accumulates, our actions and recommendations on its treatment will change. Most drugs to treat the new coronavirus infection are still under clinical trials. A vaccine has not been developed, and data on the use of plasma, convalescents, hydroxychloroquine and a number of other drugs are insufficient to provide recommendations that meet the principles of evidence-based medicine. We believe that the analysis of the first 157 fatal cases of a new coronavirus infection is only the first step in the formation of carefully verified treatment recommendations.

Keywords:

COVID-19
Coronavirus
epidemiology
mortality

Authors:

Khripun A.I.

Pirogov Russian National Research Medical University

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Zairatyants O.V.

Research Institute of Human Morphology;
Moscow State Medical and Dental University named after A.I. Evdokimov

Nikonov E.L.

Pirogov Russian National Research Medical University

Bessarab T.P.

Sverzhevskiy Research Clinical Institute of Otorhinolaryngology

Gurov A.V.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

Kishinevskiy A.E.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Krasnikova D.I.

L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology of the Moscow Health Department

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Romanenko S.G.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Samsonova M.V.

Research Institute of Pulmonology

Timofeeva M.G.

Sverzhevskiy Research Clinical Institute of Otorhinolaryngology

Chernyayev A.L.

Research Institute of Pulmonology;
Research Institute of Human Morphology;
Russian National Research Medical University named after N.I. Pirogov

Mikhaleva L.M.

A.P. Avtsyn Research Institute of Human Morphology

Mishnev O.D.

Russian National Research Medical University named after N.I. Pirogov

Received:

11.07.2020

Accepted:

12.10.2020

Close metadata

References:

  1. Vremennye metodicheskie rekomendacii Ministerstva Zdravoohraneniya RF. Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19). Versiya 6 ot 28.04.20. Accessed May 10, 2020. (In Russ.). https://static-1.rosminzdrav.ru/system/attachments/attaches/000/050/116/original/28042020_%D0%9CR_COVID-19_v6.pdf
  2. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung K, Lau E, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine. 2020;382(13):1199-207.  https://doi.org/10.1056/NEJMoa2001316
  3. Chuchalin AG, Chernyaev AL, Zayratyants OV, Kelli EI, Rogov KA, Mihaleva LM, Trusov AE, Samsonova MV, Cpartorizhskaya NN. Patologicheskaya anatomiya legkih pri grippe A(H1N1), podannymautopsij. Pul’monologiya. 2010;1:5-11. (In Russ.).
  4. Zayratyants OV, Chernyaev AL, Chuchalin AG, Polyanko NI, Kelli EI, Rogov KA, Mihaleva LM, Trusov AE, Samsonova MV, Pominal’naya VM. Patomorfologiya legkih pri tyazheloj forme grippa A(H1N1). Anesteziologiya i reanimatologiya. 2010;3:25-29. (In Russ.).
  5. Chernyaev AL, Zayratyants OV, Polyanko NI, Kelli EI, Rogov KA, Mihaleva LM, Chartorizhskaya NN, Trusov AE, Samsonova MV, Chuchalin AG. Patologicheskaya anatomiya grippa A/H1N1. Arhiv patologii. 2010(3):3-7. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.